Chemoradiation Treatment for Head and Neck Cancer

NCT00704639 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Cetuximab
DRUG: Carboplatin
RADIATION: Radiotherapy

Sponsor

Trans Tasman Radiation Oncology Group